Australia's most trusted
source of pharma news
Saturday, 19 April 2025
Posted 17 April 2025 AM
Former Australian pharma executive, Vincent So, has hit the mainstream media urging industry to take a proactive stand in the trade war debate or risk being left behind.
In an opinion piece published in the Australian Financial Review last week, So reflected that US President Donald Trump's seemingly erratic trade policy may be more nuanced and strategic that it appears - and will impact the Australian medicines industry.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.